AI English summary of an SEC filing — figures as filed

The company said David Hickey, executive vice president and president of the Life Sciences segment, informed it on February 22, 2024 of his intention to retire, effective July 1, 2024.

8-KDeparture or Appointment of Directors or Certain OfficersFiled Feb 27, 2024Period of report Feb 22, 2024Summary published (UTC) Oct 31, 2026

Key points

AI summary

The company said David Hickey, executive vice president and president of the Life Sciences segment, informed it on February 22, 2024 of his intention to retire, effective July 1, 2024.
The company said it intends to name a successor to Hickey before his retirement date. This was included in Item 5.02 and the press release.
The company said Hickey has held the post of president of the Life Sciences segment since January 2021, and was president of Integrated Diagnostic Solutions from 2019 to 2021, and before that president of Diagnostic Systems.
The company said Hickey held a range of executive positions at Siemens Healthcare before joining BD in 2014. Tom Polen, the company's chairman, CEO and president, thanked Hickey for his contributions in leading BD's development of rapid and molecular diagnostic tests during the COVID-19 pandemic.

Summary

AI-written

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

Life Sciences President David Hickey Gives Notice of Retirement

The company said David Hickey, executive vice president and president of the Life Sciences segment, informed it on February 22, 2024 of his intention to retire, effective July 1, 2024.

Source · Based on the filing body and exhibits

Plans to Name a Successor

The company said it intends to name a successor to Hickey before his retirement date. This was included in Item 5.02 and the press release.

Source · Based on the filing body and exhibits

Hickey's Career Roles at BD

The company said Hickey has held the post of president of the Life Sciences segment since January 2021, and was president of Integrated Diagnostic Solutions from 2019 to 2021, and before that president of Diagnostic Systems.

Source · Based on the filing body and exhibits

Pre-BD Career and Company Tribute

The company said Hickey held a range of executive positions at Siemens Healthcare before joining BD in 2014. Tom Polen, the company's chairman, CEO and president, thanked Hickey for his contributions in leading BD's development of rapid and molecular diagnostic tests during the COVID-19 pandemic.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

View the original filing on SEC EDGAR ↗

Unauthorized scraping, data storage and database creation prohibited

Without prior written consent, you must not crawl or scrape data compiled and organized by Chickstock or its analysis and summaries, or collect them repeatedly or in bulk for storage, ingestion or database creation. Repurposing, redistribution, sale and use to build other services are also prohibited.

Unauthorized use may result in access restrictions, demands to stop infringement and delete copies, and claims for damages. Violations of applicable law may also give rise to criminal liability.

Uses permitted by law, the Terms of Service or a separate agreement remain subject to their respective scope. Rights in individual source materials, including original filings, remain with their respective rights holders.